Impact of an exercise program on acylcarnitines in obesity: a prospective controlled study
Background Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. Methods A prospective, randomized,...
Saved in:
| Published in | Journal of the International Society of Sports Nutrition Vol. 9; no. 1; p. 22 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
10.05.2012
BioMed Central Ltd Taylor & Francis Ltd Taylor & Francis Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1550-2783 1550-2783 |
| DOI | 10.1186/1550-2783-9-22 |
Cover
| Abstract | Background
Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear.
Methods
A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m
2
. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers.
Results
The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7])
p =
0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09])
p =
0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32])
p =
0.03. Free fatty acid levels remained without change during the study in both groups.
Conclusion
In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. |
|---|---|
| AbstractList | Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m.sup.2. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers. The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups. In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. Background Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. Methods A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m.sup.2. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers. Results The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups. Conclusion In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. Keywords: Beta-oxidation, Aerobic exercise, Diabetes mellitus, Overweight, Obesity, Lipotoxicity Doc number: 22 Abstract Background: Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. Methods: A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m2 . (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers. Results: The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups. Conclusion: In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. Abstract Background Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. Methods A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m2. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers. Results The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups. Conclusion In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear.BACKGROUNDAcylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear.A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m2. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers.METHODSA prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m2. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers.The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups.RESULTSThe proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups.In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve.CONCLUSIONIn conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m2. (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers. The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups. In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. Background Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. Methods A prospective, randomized, longitudinal, interventional study in a University Research Center involved a 10-week AE program in 32 women without DM and a body mass index (BMI) greater than 27 kg/m 2 . (Cases n = 17; Controls n = 15). The primary objective was to evaluate the influence of a controlled AE program on beta-oxidation according to modifications in short, medium, and long-chain ACs. Secondary objectives were to define the behavior of amino acids, and the correlation between these modifications with metabolic and anthropometric markers. Results The proportion of dropouts was 17% and 6% in controls and cases, respectively. In cases there was a significant reduction in total carnitine (30.40 [95% CI 28.2 to 35.6]) vs. (29.4 [CI 95% 25.1 to 31.7]) p = 0.0008 and long-chain AC C14 (0.06 [95% CI 0.05 to 0.08]) vs. (0.05 [95% CI 0.05 to 0.09]) p = 0.005 and in C18 (0.31 [95% CI 0.27 to 0.45]) vs. (0.28 [95% CI 0.22 to 0.32]) p = 0.03. Free fatty acid levels remained without change during the study in both groups. Conclusion In conclusion, a controlled 10-week AE program improved beta-oxidation by reducing long-chain ACs. This finding highlights the importance that AE might have in avoiding or reverting lipotoxicity, and in consequence, improving insulin sensitivity and pancreatic beta cell functional reserve. |
| Audience | Academic |
| Author | Rodríguez-Gutiérrez, René Martínez-Garza, Laura E Torres-Sepúlveda, Maria R Mancillas-Adame, Leonardo G López-Alvarenga, Juan C González-González, Jose G Landeros-Olvera, Erick Villarreal-Pérez, Jesus Z Lavalle-González, Fernando J Salazar-Gonzalez, Bertha |
| AuthorAffiliation | 5 Investigation Department, Nursing School, Universidad Autónoma de Nuevo León, Av. Gonzalitos 1500 Norte, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico 6 Servicio de Endocrinología, Hospital Universitario Dr. José E. Gonzalez, Ave. Madero y Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico 4 Investigation Department of the Hospital General de Mexico, O.D, Dr. Balmis No.148, Col. Doctores, Delegación, Cuauhtémoc, 06726, Mexico 1 Endocrinology Division, Internal Medicine Department, “Dr. José E. González”, University Hospital and Medical School of the Universidad Autónoma de Nuevo León, Ave. Madero y Ave. Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico 3 Cardiovascular Exercise Laboratory, Nursing School of the Benemérita Universidad Autónoma de Puebla, 4 sur 104, Centro Histórico, Puebla, 72000, Mexico 2 Genetics Department, Medical School of the Universidad Autónoma de Nuevo León, Ave. Madero y Dr. Eduardo Aguirre Pequeño |
| AuthorAffiliation_xml | – name: 1 Endocrinology Division, Internal Medicine Department, “Dr. José E. González”, University Hospital and Medical School of the Universidad Autónoma de Nuevo León, Ave. Madero y Ave. Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico – name: 5 Investigation Department, Nursing School, Universidad Autónoma de Nuevo León, Av. Gonzalitos 1500 Norte, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico – name: 4 Investigation Department of the Hospital General de Mexico, O.D, Dr. Balmis No.148, Col. Doctores, Delegación, Cuauhtémoc, 06726, Mexico – name: 2 Genetics Department, Medical School of the Universidad Autónoma de Nuevo León, Ave. Madero y Dr. Eduardo Aguirre Pequeño s/n, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico – name: 3 Cardiovascular Exercise Laboratory, Nursing School of the Benemérita Universidad Autónoma de Puebla, 4 sur 104, Centro Histórico, Puebla, 72000, Mexico – name: 6 Servicio de Endocrinología, Hospital Universitario Dr. José E. Gonzalez, Ave. Madero y Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo León, 64460, Mexico |
| Author_xml | – sequence: 1 givenname: René surname: Rodríguez-Gutiérrez fullname: Rodríguez-Gutiérrez, René organization: Endocrinology Division, Internal Medicine Department, “Dr. José E. González, University Hospital and Medical School of the Universidad Autónoma de Nuevo León – sequence: 2 givenname: Fernando J surname: Lavalle-González fullname: Lavalle-González, Fernando J email: drfernandolavalle@hotmail.com organization: Endocrinology Division, Internal Medicine Department, “Dr. José E. González, University Hospital and Medical School of the Universidad Autónoma de Nuevo León, Servicio de Endocrinología, Hospital Universitario Dr. José E. Gonzalez – sequence: 3 givenname: Laura E surname: Martínez-Garza fullname: Martínez-Garza, Laura E organization: Genetics Department, Medical School of the Universidad Autónoma de Nuevo León – sequence: 4 givenname: Erick surname: Landeros-Olvera fullname: Landeros-Olvera, Erick organization: Cardiovascular Exercise Laboratory, Nursing School of the Benemérita Universidad Autónoma de Puebla – sequence: 5 givenname: Juan C surname: López-Alvarenga fullname: López-Alvarenga, Juan C organization: Investigation Department of the Hospital General de Mexico – sequence: 6 givenname: Maria R surname: Torres-Sepúlveda fullname: Torres-Sepúlveda, Maria R organization: Genetics Department, Medical School of the Universidad Autónoma de Nuevo León – sequence: 7 givenname: Jose G surname: González-González fullname: González-González, Jose G organization: Endocrinology Division, Internal Medicine Department, “Dr. José E. González, University Hospital and Medical School of the Universidad Autónoma de Nuevo León – sequence: 8 givenname: Leonardo G surname: Mancillas-Adame fullname: Mancillas-Adame, Leonardo G organization: Endocrinology Division, Internal Medicine Department, “Dr. José E. González, University Hospital and Medical School of the Universidad Autónoma de Nuevo León – sequence: 9 givenname: Bertha surname: Salazar-Gonzalez fullname: Salazar-Gonzalez, Bertha organization: Investigation Department, Nursing School, Universidad Autónoma de Nuevo León – sequence: 10 givenname: Jesus Z surname: Villarreal-Pérez fullname: Villarreal-Pérez, Jesus Z organization: Endocrinology Division, Internal Medicine Department, “Dr. José E. González, University Hospital and Medical School of the Universidad Autónoma de Nuevo León |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22574901$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktr3DAUhU1JaR7ttstiKJR24USWLNvqohBCHwOBQh-bboQkX3k0eKSpJIfMv6_cSSfjkGKwzfV3zvW9OqfZkXUWsuxlic7Lsq0vSkpRgZuWFKzA-El2si8cHbwfZ6chrBAiFWrws-wYY9pUDJUn2a_FeiNUzJ3Ohc3hFrwyAfKNd70X69zZXKjtoIS3JhoLITc2dxKCidv3uZi4sAEVzQ3kytno3TBAl4c4dtvn2VMthgAv7p5n2c9PH39cfSmuv35eXF1eF6rBOBaKYVURQhotaFvidKdaow4QbXUrJVZSUlS2laQ1kXWLm6TqKqllxyRpiCBn2WLn2zmx4htv1sJvuROG_y0433Pho1EDcIxFzSiWXc1khUQlBMMaoOwaRBjTOnl92HltRrmGTkEaSQwz0_kXa5a8dzecVLitKUoGb-8MvPs9Qoh8bYKCYRAW3Bh4iUhT07ZqaEJfP0BXbvQ2rWqiWoJZQ9A91Ys0gLHapb5qMuWXdOpKWIUTdf4Ila4O1iYdDGiT6jPBu5lgOjy4jb0YQ-CL79_m7JsDdgliiMvghjEaZ8McfHW4vf3a_sXt_jdVyk3woPdIifiUZz5Flk-R5SzJkqB6IFAmiqlxms8M_5dd7GQh-dse_OFqH1X8Ae5EBDA |
| CitedBy_id | crossref_primary_10_1038_srep26445 crossref_primary_10_1371_journal_pone_0082459 crossref_primary_10_1039_C5MB00363F crossref_primary_10_1017_S1751731119003185 crossref_primary_10_1038_s43856_024_00507_w crossref_primary_10_3389_fendo_2021_778442 crossref_primary_10_1016_j_phrs_2015_11_014 crossref_primary_10_1186_s13293_016_0077_7 crossref_primary_10_1113_EP086019 crossref_primary_10_1113_JP284142 crossref_primary_10_1038_s41598_017_06767_y crossref_primary_10_1016_j_isci_2024_109083 crossref_primary_10_1210_jc_2014_1896 |
| Cites_doi | 10.1377/hlthaff.28.5.w822 10.1007/BF00280883 10.1152/ajpendo.00551.2006 10.2337/diacare.25.7.1177 10.1210/jc.2009-2534 10.2337/diacare.24.11.1936 10.2337/diabetes.51.10.2944 10.2337/diabetes.48.9.1801 10.1038/oby.2004.92 10.2337/diab.37.12.1595 10.2337/diacare.24.4.710 10.1177/153537020222700903 10.1016/j.cmet.2007.10.013 10.2337/db07-0141 10.3945/jn.108.103754 10.1016/S0140-6736(63)91500-9 10.1152/ajpcell.1999.277.6.C1130 10.1038/oby.2009.510 10.2337/diacare.27.2.629 10.1172/JCI25758 10.1111/j.1432-1033.1997.00001.x 10.1046/j.1365-2362.32.s3.3.x 10.1001/jama.286.10.1195 10.1002/ajmg.c.30087 10.1016/j.cmet.2009.02.002 10.1053/meta.2002.34700 10.7326/0003-4819-133-2-200007180-00008 10.1590/S0036-36342010000700005 10.2337/diabetes.52.9.2191 10.1146/annurev.med.53.082901.104057 10.2337/diab.37.6.667 10.1007/BF00444658 10.2337/diacare.26.3.917 10.2337/db09-9028 10.1172/JCI114281 10.4158/EP.14.6.782 10.1210/jcem-64-1-106 |
| ContentType | Journal Article |
| Copyright | Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. COPYRIGHT 2012 BioMed Central Ltd. 2012 Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2012 Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. 2012 Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: 2012 Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2012 Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. 2012 Rodriguez-Gutierrez et al.; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION NPM ISR 3V. 7RQ 7TS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1186/1550-2783-9-22 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed Science in Context ProQuest Central (Corporate) Career & Technical Education Database Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central - New (Subscription) ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Physical Education Index ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Career and Technical Education ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Diet & Clinical Nutrition |
| EISSN | 1550-2783 |
| EndPage | 22 |
| ExternalDocumentID | oai_doaj_org_article_22a6952bd69b40a4aa92fee1d70399ff PMC3428650 2754342311 A534283942 22574901 10_1186_1550_2783_9_22 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | 0YH 29L 2VQ 2WC 4.4 53G 5GY 5VS 7RQ 7X7 88E 8FI 8FJ A8Z AAFWJ AAHBH ABUWG ACGFO ACGFS ADBBV ADFRT ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 DWQXO DXH E3Z EBLON EBS ECGQY EJD EMOBN ESTFP F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO ICU IHR IHW INH INR IPT ISR ITC KQ8 M1P M48 M4Z M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO QF4 QM9 QN7 QO4 RBZ RNS ROL RPM RSV SMD SOJ TDBHL TFL TR2 UKHRP WOQ XSB AAYXX ALIPV CITATION NPM PMFND 3V. 7TS 7XB 8FK AZQEC K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c722t-c92c43337fa5812fa55ff0de058f8bb2cbb50184b563b6827722d4bfbd9b373a3 |
| IEDL.DBID | M48 |
| ISSN | 1550-2783 |
| IngestDate | Wed Aug 27 01:28:54 EDT 2025 Thu Aug 21 18:20:15 EDT 2025 Fri Sep 05 11:08:57 EDT 2025 Wed Sep 10 04:58:18 EDT 2025 Tue Jun 17 22:05:44 EDT 2025 Tue Jun 10 21:03:31 EDT 2025 Fri Jun 27 05:57:37 EDT 2025 Thu May 22 21:23:48 EDT 2025 Mon Jul 21 06:06:47 EDT 2025 Tue Jul 01 03:48:20 EDT 2025 Thu Apr 24 23:09:03 EDT 2025 Sat Sep 06 07:29:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Obesity Beta-oxidation Lipotoxicity Diabetes mellitus Aerobic exercise Overweight |
| Language | English |
| License | http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c722t-c92c43337fa5812fa55ff0de058f8bb2cbb50184b563b6827722d4bfbd9b373a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doi.org/10.1186/1550-2783-9-22 |
| PMID | 22574901 |
| PQID | 1038329730 |
| PQPubID | 54949 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_22a6952bd69b40a4aa92fee1d70399ff pubmedcentral_primary_oai_pubmedcentral_nih_gov_3428650 proquest_miscellaneous_1037658475 proquest_journals_1038329730 gale_infotracmisc_A534283942 gale_infotracacademiconefile_A534283942 gale_incontextgauss_ISR_A534283942 gale_healthsolutions_A534283942 pubmed_primary_22574901 crossref_primary_10_1186_1550_2783_9_22 crossref_citationtrail_10_1186_1550_2783_9_22 springer_journals_10_1186_1550_2783_9_22 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-05-10 |
| PublicationDateYYYYMMDD | 2012-05-10 |
| PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-10 day: 10 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States – name: Fort Lauderdale |
| PublicationTitle | Journal of the International Society of Sports Nutrition |
| PublicationTitleAbbrev | J Int Soc Sports Nutr |
| PublicationTitleAlternate | J Int Soc Sports Nutr |
| PublicationYear | 2012 |
| Publisher | BioMed Central BioMed Central Ltd Taylor & Francis Ltd Taylor & Francis Group |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Taylor & Francis Ltd – name: Taylor & Francis Group |
| References | Boden G (CR11) 2002; 32 Gastaldelli A (CR23) 2007; 292 Boyle J (CR4) 2001; 24 DeFronzo RA (CR12) 2009; 58 Dommarco JR (CR6) 2006 He J (CR42) 2004; 12 Hogan P (CR2) 2003; 26 Koves TR (CR20) 2008; 7 Brodan V (CR40) 1976; 35 Unger RH (CR16) 2002; 53 Miyazaki Y (CR24) 2001; 24 Randle PJ (CR18) 1963; 1 DeFronzo RA (CR8) 1988; 37 Mokdad A (CR5) 2001; 286 Reaven GM (CR15) 1987; 64 Reaven GM (CR9) 1988; 37 Matsuda M (CR14) 1999; 48 Longo N (CR17) 2006; 142 Finkelstein EA (CR1) 2009; 28 Ross R (CR39) 2000; 133 Matsuda M (CR13) 2002; 51 Franck N (CR36) 2011; 96 Toledo GS (CR43) 2007; 56 Matthews DR (CR29) 1985; 28 Noble BJ (CR27) 1983; 5 Adams SH (CR31) 2009; 139 Kraemer RR (CR37) 2002; 227 Abdul-Ghani M (CR10) 2008; 14 Hiatt WR (CR25) 1989; 84 National Institutes of Health (CR28) 1998; 2 Chitwood LF (CR35) 1996; 20 Mihalik SJ (CR22) 2010; 18 McGarry JD (CR21) 1997; 244 Kelley DE (CR32) 2005; 115 Hanley AJ (CR30) 2002; 25 American College of Sports Medicine (CR26) 2010 Kriketos AD (CR38) 2004; 27 Kelley DE (CR33) 1999; 277 Goodpaster BH (CR34) 2003; 52 Villalpando Hernandez S (CR7) 2010; 52 World Health Organization (CR3) 2000 Newgard CB (CR41) 2009; 9 Kelley DE (CR19) 2002; 51 |
| References_xml | – volume: 28 start-page: 822 year: 2009 ident: CR1 publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.28.5.w822 – volume: 28 start-page: 412 year: 1985 ident: CR29 publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 292 start-page: 871 year: 2007 ident: CR23 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00551.2006 – volume-title: World Health Organization Consultation on Obesity year: 2000 ident: CR3 – volume: 25 start-page: 1177 year: 2002 ident: CR30 publication-title: Diabetes Care doi: 10.2337/diacare.25.7.1177 – volume: 96 start-page: 413 year: 2011 ident: CR36 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-2534 – volume: 24 start-page: 1936 year: 2001 ident: CR4 publication-title: Diabetes Care doi: 10.2337/diacare.24.11.1936 – volume: 2 start-page: 461 issue: 6 year: 1998 ident: CR28 publication-title: Obes Res – volume: 51 start-page: 2944 year: 2002 ident: CR19 publication-title: Diabetes doi: 10.2337/diabetes.51.10.2944 – volume: 48 start-page: 1801 year: 1999 ident: CR14 publication-title: Diabetes doi: 10.2337/diabetes.48.9.1801 – volume: 12 start-page: 761 year: 2004 ident: CR42 publication-title: Obes Res doi: 10.1038/oby.2004.92 – volume: 37 start-page: 1595 year: 1988 ident: CR9 publication-title: Diabetes doi: 10.2337/diab.37.12.1595 – volume: 24 start-page: 710 year: 2001 ident: CR24 publication-title: Diabetes Care doi: 10.2337/diacare.24.4.710 – volume: 227 start-page: 701 year: 2002 ident: CR37 publication-title: Exp Biol Med doi: 10.1177/153537020222700903 – volume: 7 start-page: 45 year: 2008 ident: CR20 publication-title: Cell Metab doi: 10.1016/j.cmet.2007.10.013 – volume-title: Nutrición. In Encuesta Nacionalde Saludy Nutrición year: 2006 ident: CR6 – volume: 56 start-page: 2142 year: 2007 ident: CR43 publication-title: Diabetes doi: 10.2337/db07-0141 – volume: 139 start-page: 1073 year: 2009 ident: CR31 publication-title: J Nutr doi: 10.3945/jn.108.103754 – volume: 1 start-page: 785 year: 1963 ident: CR18 publication-title: Lancet doi: 10.1016/S0140-6736(63)91500-9 – volume: 277 start-page: 1130 year: 1999 ident: CR33 publication-title: Am J Physiol doi: 10.1152/ajpcell.1999.277.6.C1130 – volume: 18 start-page: 1695 year: 2010 ident: CR22 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2009.510 – volume: 27 start-page: 629 year: 2004 ident: CR38 publication-title: Diabetes Care doi: 10.2337/diacare.27.2.629 – volume: 115 start-page: 1699 year: 2005 ident: CR32 publication-title: J Clin Invest doi: 10.1172/JCI25758 – volume: 244 start-page: 1 year: 1997 ident: CR21 publication-title: Eur J Biochem doi: 10.1111/j.1432-1033.1997.00001.x – volume: 32 start-page: 14 issue: 3 year: 2002 ident: CR11 publication-title: Eur J Clin Invest doi: 10.1046/j.1365-2362.32.s3.3.x – volume: 286 start-page: 1195 year: 2001 ident: CR5 publication-title: J Am Med Assoc doi: 10.1001/jama.286.10.1195 – volume: 142 start-page: 77 year: 2006 ident: CR17 publication-title: Am J Med Genet C Semin Med Genet doi: 10.1002/ajmg.c.30087 – volume: 9 start-page: 311 year: 2009 ident: CR41 publication-title: Cell Metab doi: 10.1016/j.cmet.2009.02.002 – volume: 51 start-page: 1111 year: 2002 ident: CR13 publication-title: Metabolism doi: 10.1053/meta.2002.34700 – volume: 133 start-page: 92 year: 2000 ident: CR39 publication-title: Ann Intern Med doi: 10.7326/0003-4819-133-2-200007180-00008 – volume: 52 start-page: 19 year: 2010 ident: CR7 publication-title: Salud Pública de México doi: 10.1590/S0036-36342010000700005 – volume: 52 start-page: 2191 year: 2003 ident: CR34 publication-title: Diabetes doi: 10.2337/diabetes.52.9.2191 – volume: 53 start-page: 319 year: 2002 ident: CR16 publication-title: Annu Rev Med doi: 10.1146/annurev.med.53.082901.104057 – volume: 37 start-page: 667 year: 1988 ident: CR8 publication-title: Diabetes doi: 10.2337/diab.37.6.667 – volume: 20 start-page: 455 year: 1996 ident: CR35 publication-title: Int J Obes Relat Metab Disord – volume-title: ACSM’s Guidelines for exercise testing and prescription year: 2010 ident: CR26 – volume: 35 start-page: 69 year: 1976 ident: CR40 publication-title: Europ J appl Physiol doi: 10.1007/BF00444658 – volume: 26 start-page: 917 year: 2003 ident: CR2 publication-title: Diabetes Care doi: 10.2337/diacare.26.3.917 – volume: 58 start-page: 773 year: 2009 ident: CR12 publication-title: Diabetes doi: 10.2337/db09-9028 – volume: 84 start-page: 1167 year: 1989 ident: CR25 publication-title: J Clin Invest doi: 10.1172/JCI114281 – volume: 14 start-page: 782 year: 2008 ident: CR10 publication-title: Endocr Pract doi: 10.4158/EP.14.6.782 – volume: 64 start-page: 106 year: 1987 ident: CR15 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-64-1-106 – volume: 5 start-page: 523 year: 1983 ident: CR27 publication-title: Med Sci Sports Exerc |
| SSID | ssj0034072 |
| Score | 1.9833235 |
| Snippet | Background
Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM).... Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect... Background Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM).... Doc number: 22 Abstract Background: Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type... Abstract Background Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 22 |
| SubjectTerms | Aerobic exercise Beta-oxidation Body mass index Carnitine Clinical Nutrition Complications and side effects Diabetes Diabetes mellitus Exercise Fatty acids Insulin resistance Lipotoxicity Medicine Medicine & Public Health Obesity Overweight Pancreatic beta cells Physiological aspects Research Article Risk factors Sports Medicine Studies Type 2 diabetes Weight control |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgvIKFDAIUS5Rs37G3MqjapHaA1Cp4mLZjg0rrRLUzR767_E4TrQpIC5c9hB_0Sbz8jgef4PQKypECITZ0tImxAUKZdHnOCmtqIKU0TWr9Oni9Ewcn7NPF_xiq9UX1IQN9MCD4A4IMUJxYhuhLKsMM0aR4P2iiaaqVAgQfeM0Ni6mhhhMgfYrMaXyqoReEpmucVGLg-laqUpCZtNRYu3_PTZvTU7XCyev7Z6mSenoDrqds0l8OLzFXXTDt7uo-LD0PX6NM-XnCp-NjPu76OZp3ku_h76dpAOSuAvYtHhsvYRzwRbuWmzc1crBl5MeauPxssXd0EbgLTaAG09p4lzvvvINTnS199H50cev74_L3GmhdJKQvnSKOEYplcHwOOPHXx5C1fiK16G2ljhrgfiPWS6oFTWJKTlpmA22UZZKaugDtNN2rX-EsPdhARyGUUWOuWDMQgoHXbGYhC3bpkDlKHDtMg05dMNY6bQcqYUGBWlQkFaakALtT_ifAwHHX5HvQH8TCoiz04VoTjqbk_6XORXoOWhfD6dQJ_fXh5wCNZ1i8W9eJgSQZ7RQnfPdbNZrffLl8wy0n0Ghi2_nTD7sEGUEfFsz5N4MGb3bzYdHM9Q5uqw1kNpTaDpWFejFNAx3QsVc67tNwkjILiUv0MPBaifJxBguWVRGgeTMnmeim4-0yx-JexyeKyb1BXozWv72Y_1JLY__h1qeoFsxUyVlos3dQzv95cY_jdlgb58lx_8FVKlXig priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLKuXR0AIGIcrFamI7dsIFlUfVIrUHoNKKi2U7dllplZRu9sC_x-N1QlMelxzW3yqO5-GxPf4GoZdMCO8pN8SwxocFCuPB5kpKjMi9lME087h1cXIqjs74p1k5Sxtuy5RWOfjE6KibzsIe-T4QeTMotJS_vfhBoGoUnK6mEho30a0ihCqg1XI2LrgYkH8losaiEvsQjROoLEFqQulkIop8_X965SvT0vWUyWvnpnE6OtxEd1MciQ_Wgr-Hbrh2C2Uf5q7Hr3Ai-1zg04FrfwvdPkmn6PfRt-N4NRJ3HusWD0WXcErVwl2Ltf25sLBn0kNWPJ63uFsXEHiDNeCG-5k4ZbovXIMjUe0DdHb48ev7I5JqLBArKe2JranljDHpdRnm-vAsvc8bl5eVr4yh1hig_OOmFMyIioZgnDbceNPUhkmm2UO00Xat20bYOV8Ae6FzheXWa11IYaEeFpdwWNtkiAwDrmwiIIc6GAsVFyKVUCAgBQJStaI0Q3sj_mJNvfFP5DuQ34gCyuz4Q3d5rpIFBpgWdUlNI2rDc821rqkPfW2Cz6tr7zP0DKSv1vdPR8NXByUDUrqah9e8iAigzWghL-dcr5ZLdfzl8wS0l0C-C19ndbrmEMYImLYmyN0JMti1nTYPaqiSX1mq31aQoedjM_wTcuVa160iRkJcKcsMPVpr7TgywXtLHoSRITnR58nQTVva-ffIOg79CuF8hl4Pmn-1W38Ty-P_f8EOuhOiT0oiFe4u2ugvV-5JiPB68zSa8S8zz0ym priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZQkRAXBOUVWsAgRLlEZG3HTriVhapFag9ApYqLZTt2WWmVoO7ugX_PjONEmxYkLjmsvyhez8OTeOYbQt5wKUNgwuaWNwFeULgAmytZbmURlALTLOKni9MzeXwuvlyUFylBFmthts_vZ5V8jxF0jt0g8jpn4Gpvl-B0MXVvLueDx-VI8pUIGW_eM9lwIi__Te-7tf1cT428dj4at52j--ReihfpYS_gB-SWb3dJ9mnh1_QtTaSeS3o2cOrvkjun6bT8IflxEksgaReoaenQXImmlCzatdS430uH30bWmP1OFy3t-kYBH6hB3FCHSVNG-9I3NBLSPiLnR5-_z4_z1Eshd4qxde5q5gTnXAVTwp4O1zKEovFFWYXKWuasRWo_YUvJrawYBN2sETbYprZcccMfk522a_1TQr0PM2Qp9H7mhAvGzJR02PdKKDyUbTKSDwuuXSIax34XSx1fOCqpUUAaBaRrzVhGDkb8r55i45_Ijyi_EYXU2PEH0BidLA1gRtYls42srSiMMKZmAebagG-r6xAy8hKlr_s609HA9WHJkXyuFvCY1xGB9Bgt5t9cms1qpU--fZ2ADhIodPDvnEnlDLBGyKg1Qe5PkGC_bjo8qKFO_mOlkbaeY1uxIiOvxmG8E3PiWt9tIkZh_KjKjDzptXZcGfDSSoAwMqIm-jxZuulIu_gZ2cVxXhC2Z-TdoPnb0_qbWJ79P3SP3IWIk-WR_naf7KyvNv45RHVr-yKa9B8FPUN2 priority: 102 providerName: Springer Nature |
| Title | Impact of an exercise program on acylcarnitines in obesity: a prospective controlled study |
| URI | https://link.springer.com/article/10.1186/1550-2783-9-22 https://www.ncbi.nlm.nih.gov/pubmed/22574901 https://www.proquest.com/docview/1038329730 https://www.proquest.com/docview/1037658475 https://pubmed.ncbi.nlm.nih.gov/PMC3428650 https://doaj.org/article/22a6952bd69b40a4aa92fee1d70399ff |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: RBZ dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: KQ8 dateStart: 20040101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: GX1 dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: M~E dateStart: 20040101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1550-2783 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: M48 dateStart: 20040601 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1550-2783 dateEnd: 20211231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: C6C dateStart: 20040601 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 1550-2783 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0034072 issn: 1550-2783 databaseCode: 0YH dateStart: 20050601 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3taxMxGA-6gfhFdL6dzhpFnF9Or0ku6QkiW93YhBaZFopfQpJLZqHcaV_A_ffmSXPnbpv4pdDmdzT3vCRPkie_B6FXlHPnCNOppqXzCxTKvM_lJNU8c0J418zC1sVozI8n7PM0n_7Nf4oCXF67tIN6UpPF_O3vX-cfvcN_CA4_4O8gyk6hYkRapMQPx9t-ViJg4SPWnihQIAIL3KkRGwkcrz7fmaACj__V0frCdHU5lfLSeWqYpo7uojsxvsT7G4O4h27Yagcln2Z2hV_jSAI6x-OGg38H3RrF0_X76PtJuDKJa4dVhZtiTDimcOG6wsqczw3spawgWx7PKlxvCgu8xwpwzb1NHDPg57bEgcD2AZocHX4bHqex9kJqBCGr1BTEMEqpcCr3MYD_zJ3LSpvlAzfQmhitgQqQ6ZxTzQfEB-mkZNrpstBUUEUfoq2qruxjhK11fWA1tLZvmHFK9QU3UCeLCTjELROUNgKXJhKTQ32MuQwLlAGXoCAJCpKFJCRBey3-54aS45_IA9BfiwIq7fBDvTiT0TM9TPEiJ7rkhWaZYkoVxPm-ln4sLArnEvQctC8391LbAUHu5xTI6grm_-ZlQACdRgX5OmdqvVzKk6-nHdBeBLnav51R8fqDlxEwcHWQux2k93fTbW7MUDbuIoHmnkIZsixBL9pmeBJy6CpbrwNGQLwp8gQ92lhtKxk_qgvmlZEg0bHnjui6LdXsR2Ajh375MD9BbxrLv9it69Ty5L8SfYpu-8CUpIEldxdtrRZr-8wHfyvdQzfFVPTQ9sHh-Mup_zbkw17YSOkFf_8D-aZWJA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkGAvCMbHAoMZBIyXaKntxA0SQoMxtWztA2xSxYuxHXtUqpKxtkL7p_gb8TlOWMbH2176UP_SOr7z3dk-_w6h5zTLrCVMxYoW1i1QKHNzLiWxyhLLuZuaid-6GI2zwTH7OEknK-hncxcG0iobm-gNdVFp2CPfASJvCoWWkren32OoGgWnq00JjVotDsz5D7dkm78Z7jn5viBk_8PR-0EcqgrEmhOyiHVONKOUcitT593cZ2ptUpgk7du-UkQrBSR3TKUZVVmfuPCTFExZVeSKciqp-91r6DqjCQOufj5pF3gUyMYCMWSvn-1A9B9DJYs4jwnpOD5fH-BPL3DBDV5O0bx0Tuvd3_5tdCvErXi3VrQ7aMWU6yjam5oFfokDuegMjxtu_3V0YxRO7e-iL0N_FRNXFssSN0WecEgNw1WJpT6fadijWUAWPp6WuKoLFrzGEnDNfVAcMutnpsCeGPceOr6S0b-PVsuqNBsIG2N7wJZoTE8zbaXs8UxD_S3G4XC4iFDcDLjQgfAc6m7MhF_49DMBAhIgIJELQiK03eJPa6qPfyLfgfxaFFB0-y-qsxMRZryDySxPiSqyXLFEMilzYl1fC2dj89zaCG2B9EV937U1NGI3pUCClzP3N888Amg6SsgDOpHL-VwMP3_qgLYDyFbu7bQM1yrcGAGzVwe52UE6O6K7zY0aimDH5uL3rIvQ07YZnoTcvNJUS4_hEMfyNEIPaq1tR8Z5C86cMCLEO_rcGbpuSzn95lnOoV9u-RChV43mX-zW38Ty8P9vsIVuDo5Gh-JwOD54hNZc5EtiT8O7iVYXZ0vz2EWXC_XET2mMvl61DfkFECCJmg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELWqIlVcEC1faQs1CFEuUbO2YyeIS9my6gJdIaBSxcWyHbustEqqbvbAv8fjOKumBYlLDvGL4ng843E88wah15Rz5wjTqaaV8xsUyrzO5STVPHNCeNXMwq-Lsxk_PWefLvKLDfS-z4UJ0e79kWSX0wAsTXV7dFW5TsULfgR-dQo1ItIyJd4A3wOeLmDOH_Nxb4cpUH9Fmsa7zwyWocDWf9cm31iUbgdM3jo1DYvR5CF6EL1IfNyJfRtt2HoHJSdz2-I3OFJ9LvCsZ9rfQVtn8Qz9Efo5DYmRuHFY1bgvuYRjoBZuaqzM74WBPyYtxMTjeY2brnzAO6wA12dn4hjnvrAVDjS1j9H55OOP8WkaKyykRhDSpqYkhlFKhVO5X-n9NXcuq2yWF67QmhitgfCP6ZxTzQviXXFSMe10VWoqqKJP0Gbd1PYZwta6EXAXWjsyzDilRoIbqIbFBBzVVglK-wGXJtKPQxWMhQzbkIJLEJAEAclSEpKgwzX-qiPe-CfyA8hvjQLC7HCjub6UUf88TPEyJ7ripWaZYkqVxPm-Vt7ilaVzCToA6csu-3St9vI4p0BJVzL_mlcBAaQZNUTlXKrVcimn378NQIcR5Br_dUbFJAc_RsCzNUDuD5Beq82wuZ-GMlqVpQQyewrFxrIEvVw3w5MQKVfbZhUwArxKkSfoaTdr1yPjbbdgXhgJEoP5PBi6YUs9_xU4x6Ff3plP0Nt-5t_s1t_Esvv_0AO09fVkIr9MZ5_30H3vkpI08OPuo832emWfe7ev1S-Cdv8ByupOtQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+an+exercise+program+on+acylcarnitines+in+obesity%3A+a+prospective+controlled+study&rft.jtitle=Journal+of+the+International+Society+of+Sports+Nutrition&rft.au=Torres-Sep%C3%BAlveda%2C+Maria+R&rft.au=Rodr%C3%ADguez-Guti%C3%B1rrez%2C+Ren%C3%B1&rft.au=Mancillas-Adame%2C+Leonardo+G&rft.au=Gonz%C3%A1lez-Gonz%C3%A1lez%2C+Jose+G&rft.date=2012-05-10&rft.pub=BioMed+Central+Ltd&rft.issn=1550-2783&rft.eissn=1550-2783&rft.volume=9&rft_id=info:doi/10.1186%2F1550-2783-9-22&rft.externalDBID=n%2Fa&rft.externalDocID=A534283942 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-2783&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-2783&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-2783&client=summon |